How One Advocate Went from Losing His Hearing to Being Heard

Matt Hay, U.S. Director of advocacy for NF1 at Alexion, discusses his own journey as someone living with a rare disease, neurofibromatosis, and how his experience led him to become a patient advocate within the biopharmaceutical industry.